GTS Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-69,700
Closed -$61.8M – 2834
2024
Q3
$61.8M Sell
69,700
-9,100
-12% -$8.18M 0.13% 81
2024
Q2
$71.3M Buy
78,800
+18,700
+31% +$15M 0.15% 69
2024
Q1
$46.8M Sell
60,100
-30,100
-33% -$21.4M 0.09% 109
2023
Q4
$52.6M Sell
90,200
-14,800
-14% -$8.64M 0.09% 113
2023
Q3
$56.4M Buy
+105,000
New +$54.1M 0.1% 100

Other funds holding LLY

GTS Securities's LLY Position: Q3 2026 in Review

GTS Securities increased its Eli Lilly (LLY) stake by 305% in Q3 2026, buying an estimated $6.36M and bringing the position to 7,153 shares worth $8.28M. The position accounts for 0.18% of the portfolio, ranked #87.

GTS Securities first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. The position peaked at $14.7M in Q3 2024. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • GTS Securities held 7,153 shares of Eli Lilly worth $8.28M as of Q3 2026.
  • GTS Securities bought 5,389 Eli Lilly shares in Q3 2026, an estimated $6.36M.
  • Eli Lilly made up 0.18% of GTS Securities's portfolio in Q3 2026, its #87 holding.
  • GTS Securities first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
  • GTS Securities's Eli Lilly position peaked at $14.7M in Q3 2024.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.